Sign In
Buy AXSM
$233.49
+11.33 (+5.10%)
At Close: Jun 03, 2026
Axsome: Strong Earnings Signal More Upside
02:40am, Thursday, 24'th Nov 2022
As Auvelity is recently approved, Axsome now has two solid drugs that are likely to generate significant market traction. Toward year-end, Axsome will report data of the ACCORD trial that further woul
Axsome Therapeutics to Present at the 5th Annual Evercore ISI HealthCONx Conference
07:00am, Wednesday, 23'rd Nov 2022
NEW YORK, Nov. 23, 2022 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system
Got $500? 3 Growth Stocks to Buy That Could Double Your Money
06:30am, Sunday, 20'th Nov 2022
Innovative products and services could keep these companies growing.
These 3 Stocks Are Crushing the Market. Wall Street Thinks They Can Soar at Least 78% Higher.
05:52am, Friday, 18'th Nov 2022
The good times could keep on rolling for these big winners.
Is Axsome Therapeutics Stock a Buy Now?
10:07am, Friday, 11'th Nov 2022
The company seems to be coming into its own.
Axsome (AXSM) Q3 Loss Narrower Than Expected, Revenues Miss
04:20pm, Tuesday, 08'th Nov 2022 Zacks Investment Research
Axsome (AXSM) reports a narrower-than-expected loss in the third quarter. Revenues comprise sales of the sleep drug, Sunosi, acquired from Jazz.
Why Axsome Therapeutics Stock Is Bolting Higher Today
01:41pm, Tuesday, 08'th Nov 2022
The biotech's promising Q3 earnings report has investors excited about the future.
Axsome (AXSM) Q3 Loss Narrower Than Expected, Revenues Miss
12:47pm, Tuesday, 08'th Nov 2022
Axsome (AXSM) reports a narrower-than-expected loss in the third quarter. Revenues comprise sales of the sleep drug, Sunosi, acquired from Jazz.
Why Axsome Therapeutics Stock Slipped Today
11:52pm, Monday, 07'th Nov 2022 The Motley Fool
Investors traded out of the company following the latest earnings release, but only to a modest degree.
Why Axsome Therapeutics Stock Slipped Today
06:52pm, Monday, 07'th Nov 2022
Investors traded out of the company following the latest earnings release, but only to a modest degree.
Axsome Therapeutics (AXSM) Q3 2022 Earnings Call Transcript
05:00pm, Monday, 07'th Nov 2022 The Motley Fool
AXSM earnings call for the period ending September 30, 2022.
Axsome Therapeutics, Inc. (AXSM) Q3 2022 Earnings Call Transcript
01:29pm, Monday, 07'th Nov 2022
Start Time: 08:00 January 1, 0000 8:48 AM ET Axsome Therapeutics, Inc. (NASDAQ:AXSM ) Q3 2022 Earnings Conference Call November 07, 2022, 08:00 AM ET Company Participants Herriot Tabuteau - Chairman a
Axsome Therapeutics (AXSM) Reports Q3 Loss, Tops Revenue Estimates
09:48am, Monday, 07'th Nov 2022
Axsome (AXSM) delivered earnings and revenue surprises of 6.36% and 1.56%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
2 Healthcare Stocks Poised to Rocket Higher in the 4th Quarter
10:00pm, Sunday, 06'th Nov 2022 The Motley Fool
These two healthcare stocks could deliver market-crushing gains by year's end.
2 Healthcare Stocks Poised to Rocket Higher in the 4th Quarter
05:00pm, Sunday, 06'th Nov 2022
These two healthcare stocks could deliver market-crushing gains by year's end.
